Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEROPOSTALE INCAROPQ · Entity 180405 | Director | December 09, 2016 | December 14, 2016 |
| HEALTHEQUITY, INC.HQY · Entity 3639 | Director | June 25, 2026 | June 29, 2026 |
| PACS Group, Inc.PACS · Entity 2590 | Director | July 01, 2026 | July 06, 2026 |
| QuidelOrtho CorpQDEL · Entity 4986 | Director | June 25, 2026 | June 29, 2026 |
| SOMNIGROUP INTERNATIONAL INC.SGI · Entity 3403 | Director | May 13, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEROPOSTALE INC
Report date December 09, 2016 · Filed December 14, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-12-09 transaction · row 1
1 source rowRow 1 · 2016-12-09 · Sale · Disposed 20,000 · Balance 0 |
HEALTHEQUITY, INC.
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,085 |
Reported balance
After 2026-06-25 transaction · row 1
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 2,877 · Balance 51,085 F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered to the reporting person upon vesting. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.41 · Expires 2028-02-01 | Direct | 4,339 |
Reported balance
Holding disclosure · report date 2026-06-25 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 4,339 F2: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.06 · Expires 2030-02-01 | Direct | 4,012 |
Reported balance
Holding disclosure · report date 2026-06-25 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 4,012 F2: The option is immediately exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered to the reporting person upon vesting.
F2: The option is immediately exercisable.
PACS Group, Inc.
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,085 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 4,287 · Balance 36,085 F1: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer.
QuidelOrtho Corp
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (Equity Grant)SEC Table II · derivative / convertible security | Direct | 15,532 |
Reported balance
After 2026-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 15,532 · Balance 15,532 F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2: The restricted stock units will vest on June 25, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F2: The restricted stock units will vest on June 25, 2027.
SOMNIGROUP INTERNATIONAL INC.
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 156,574 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 2,657 · Balance 156,574 F1: Each restricted stock unit represents the right to receive one share of common stock of the issuer as described in the next sentence. The restricted stock units vest in full on the first year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one share of common stock of the issuer as described in the next sentence. The restricted stock units vest in full on the first year anniversary of the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Ortho Clinical Diagnostics Holdings plc
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, $0.00001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 1
1 source rowRow 1 · 2022-05-27 · Disposition to issuer · Disposed 5,200 · Balance 0 F1: Includes 2,600 restricted stock units. F2: Pursuant to the Business Combination Agreement, dated December 22, 2021, by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time"). At the Effective Time: (a) each of the Issuer's ordinary shares was automatically converted into the right to receive (i) 0.1055 shares of common stock of Coronado Topco and (ii) $7.14 in cash; and (b) each restricted stock unit, whether vested or unvested, was converted into a Coronado Topco equity right of the same type and on the same terms and conditions as were applicable to the corresponding restricted stock unit immediately prior to the Effective Time, which right shall be settled in cash upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 2,600 restricted stock units.
F2: Pursuant to the Business Combination Agreement, dated December 22, 2021, by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time"). At the Effective Time: (a) each of the Issuer's ordinary shares was automatically converted into the right to receive (i) 0.1055 shares of common stock of Coronado Topco and (ii) $7.14 in cash; and (b) each restricted stock unit, whether vested or unvested, was converted into a Coronado Topco equity right of the same type and on the same terms and conditions as were applicable to the corresponding restricted stock unit immediately prior to the Effective Time, which right shall be settled in cash upon vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2022 Filed Jan 3, 2023 21:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-000192 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68 Underlying: Common Stock · 69 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: 69 shares vested on December 31, 2022; the remaining 68 shares will vest on March 31, 2023. F3 · derivative.expiration_date: 69 shares vested on December 31, 2022; the remaining 68 shares will vest on March 31, 2023. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 21:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-000192 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:39 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051851 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137 Underlying: Common Stock · 69 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: 69 shares vested on September 30, 2022; of the remaining 137 shares, 69 shares will vest on December 31, 2022, and 68 shares will vest on March 31, 2023. F3 · derivative.expiration_date: 69 shares vested on September 30, 2022; of the remaining 137 shares, 69 shares will vest on December 31, 2022, and 68 shares will vest on March 31, 2023. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:39 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051851 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 20:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | Exercise / conversionRestricted Stock Units · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040216 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206 Underlying: Common Stock · 69 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: 207 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 68 shares will vest on March 31, 2023. F3 · derivative.expiration_date: 207 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 68 shares will vest on March 31, 2023. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 20:15 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040216 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 23:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 2,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006999 · form4-06272022_040609.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,959 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's next annual stockholder meeting, which is expected to be held in June of 2023. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:18 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035175 · doc4.xml · derivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 21:31 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020482 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275 Underlying: Common Stock · 275 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F3 · kind: Pursuant to the Business Combination Agreement, each Ortho restricted stock unit was converted into a restricted stock unit representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement. F4 · derivative.exercise_date: 204 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 71 shares will vest on March 31, 2023. F4 · derivative.expiration_date: 204 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 71 shares will vest on March 31, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 21:31 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 274 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-020482 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274 F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash. F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 20:00 UTC | Ortho Clinical Diagnostics Holdings plc OCDX · Entity 126680 | Disposition to issuerOrdinary Shares, $0.00001 par value | 5,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-033120 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 2,600 restricted stock units. F2 · price: Pursuant to the Business Combination Agreement, dated December 22, 2021, by and among Coronado Topco, Inc. ("Coronado Topco"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the "Effective Time"). At the Effective Time: (a) each of the Issuer's ordinary shares was automatically converted into the right to receive (i) 0.1055 shares of common stock of Coronado Topco and (ii) $7.14 in cash; and (b) each restricted stock unit, whether vested or unvested, was converted into a Coronado Topco equity right of the same type and on the same terms and conditions as were applicable to the corresponding restricted stock unit immediately prior to the Effective Time, which right shall be settled in cash upon vesting. Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:08 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | GrantCommon Stock | 5,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001206264-22-000135 · wf-form4_165212689641993.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,569 F1 · shares: Each restricted stock unit represents the right to receive one share of common stock of the issuer as described in the next sentence. The restricted stock units vest in full on the first year anniversary of the grant date. The vested shares will be delivered to the reporting person on such vesting date unless an election has been made by the reporting person to defer receipt of such shares to a later date. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 17:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 727 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000757 · edgar.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,235 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's annual stockholder meeting held in the current fiscal year. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| February 01, 2022 Filed Apr 29, 2022 21:52 UTC Amendment | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 1,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002757 · edgar.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,963 F1 · shares: This amendment is being filed to correct an error in the number of shares of Common Stock reported as acquired in the original Form 4. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's annual stockholder meeting held in the current fiscal year. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 00:13 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | PurchaseCommon Stock | 5,018 | $39.79 | $199,665.72 |
DisclosureSEC source: 0001179110-21-011078 · edgar.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,508 Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Option (right to buy) · Derivative | 4,092 | $0.00 Strike: $15.51 | $0.00 |
DisclosureSEC source: 0001206264-21-000255 · wf-form4_163821975679521.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,092 shares Expires 2022-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was previously reported as covering 1,023 shares at an exercise price of $62.03 per share, vesting in four quarterly installments on July 31, 2012, October 31, 2012, January 31, 2013 and April 30, 2013. The option and exercise price have been adjusted to reflect the 4-for-1 stock split, which occurred on November 24, 2020. F1 · derivative.underlying_shares: The option was previously reported as covering 1,023 shares at an exercise price of $62.03 per share, vesting in four quarterly installments on July 31, 2012, October 31, 2012, January 31, 2013 and April 30, 2013. The option and exercise price have been adjusted to reflect the 4-for-1 stock split, which occurred on November 24, 2020. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 1,451 | $43.96 | $63,785.96 |
DisclosureSEC source: 0001206264-21-000255 · wf-form4_163821975679521.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,564 Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 4,092 | $15.51 | $63,466.92 |
DisclosureSEC source: 0001206264-21-000255 · wf-form4_163821975679521.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2021 Filed May 10, 2021 20:18 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | GrantCommon Stock | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001206264-21-000162 · wf-form4_162067788571974.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,923 F1 · shares: Each restricted stock unit represents the right to receive one share of common stock of the issuer as described below. The restricted stock units vest in full on the first year anniversary of the grant date. The vested shares will be delivered to the reporting person on such vesting date unless an election has been made by the reporting person to defer receipt of such shares to a later date. Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:00 UTC | Ortho Clinical Diagnostics Holdings plc OCDX · Entity 126680 | GrantOrdinary Shares | 5,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030365 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 F1 · shares: Represents restricted stock units, which vest in eight equal quarterly installments beginning on June 30, 2021. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Option (right to buy) · Derivative | 2,716 | $33.82 Strike: $15.43 | $91,855.12 |
DisclosureSEC source: 0001206264-21-000061 · wf-form4_161437361622908.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,716 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was previously reported as covering 679 shares at an exercise price of $61.72 per share, vesting in four quarterly installments on July 31, 2011, October 31, 2011, January 31, 2012 and April 30, 2012. The option and exercise price have been adjusted to reflect the 4-for-1 stock split, which occurred on November 24, 2020. F3 · derivative.underlying_shares: The option was previously reported as covering 679 shares at an exercise price of $61.72 per share, vesting in four quarterly installments on July 31, 2011, October 31, 2011, January 31, 2012 and April 30, 2012. The option and exercise price have been adjusted to reflect the 4-for-1 stock split, which occurred on November 24, 2020. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 2,716 | $33.82 | $91,852.95 |
DisclosureSEC source: 0001206264-21-000061 · wf-form4_161437361622908.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.81 to $33.82. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:07 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 2,716 | $15.43 | $41,907.88 |
DisclosureSEC source: 0001206264-21-000061 · wf-form4_161437361622908.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On November 24, 2020 the common stock of Tempur Sealy International, Inc. split 4-for-1, resulting in the reporting person's ownership of 90,978 additional shares of common stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:00 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 2,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001217 · edgar.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,490 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,133 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2022. Vested shares will be delivered to the reporting person on February 1, 2023. Read SEC document |
| May 07, 2020 Filed May 11, 2020 22:09 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | GrantCommon Stock | 2,415 | $53.84 | $130,023.60 |
DisclosureSEC source: 0001206264-20-000152 · wf-form4_158923494428650.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,326 F1 · price: Each deferred stock unit represents the right to receive one share of common stock of the issuer at the end of the deferral period described below. The deferred stock units vest equally on the following dates July 31, 2020; October 31, 2020; January 31, 2021; and April 30, 2021. The vested shares will be delivered to the reporting person on May 7, 2023, unless an election is made by the reporting person to defer receipt of such shares to a later date. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:01 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 187 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001206264-20-000126 · wf-form4_158767209454269.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 187 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options vested in four equal installments on the following dates: July 31, 2010, October 31, 2010, January 31, 2011 and April 30, 2011. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:01 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 158 | $41.28 | $6,522.24 |
DisclosureSEC source: 0001206264-20-000126 · wf-form4_158767209454269.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,911 F2 · kind: The sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 20:01 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 187 | $33.33 | $6,232.71 |
DisclosureSEC source: 0001206264-20-000126 · wf-form4_158767209454269.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The conversion of stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:04 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 189 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001206264-20-000094 · wf-form4_158508024063905.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187 Underlying: Common Stock · 189 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options vested in four equal installments on the following dates: July 31, 2010, October 31, 2010, January 31, 2011 and April 30, 2011. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:04 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 189 | $34.33 | $6,488.37 |
DisclosureSEC source: 0001206264-20-000094 · wf-form4_158508024063905.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,882 F2 · kind: The sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 20:04 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 189 | $33.33 | $6,299.37 |
DisclosureSEC source: 0001206264-20-000094 · wf-form4_158508024063905.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The conversion of stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 189 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001206264-20-000081 · wf-form4_158257814840890.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376 Underlying: Common Stock · 189 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options vested in four equal installments on the following dates: July 31, 2010, October 31, 2010, January 31, 2011 and April 30, 2011. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 72 | $93.84 | $6,756.48 |
DisclosureSEC source: 0001206264-20-000081 · wf-form4_158257814840890.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,882 F2 · kind: The sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 189 | $33.33 | $6,299.37 |
DisclosureSEC source: 0001206264-20-000081 · wf-form4_158257814840890.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The conversion of stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:43 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 4,012 | $0.00 Strike: $66.06 | $0.00 |
DisclosureSEC source: 0001179110-20-001037 · edgar.xml · derivative · entry 6 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,012 Underlying: Common Stock · 4,012 shares Expires 2030-02-01 F3 · derivative.exercise_date: The option becomes exercisable as to 2,006 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will become exercisable on January 31, 2021. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:43 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantCommon Stock | 1,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001037 · edgar.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,224 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 719 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2021. Vested shares will be delivered to the reporting person upon vesting. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:11 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 189 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001206264-20-000035 · wf-form4_157972747625593.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565 Underlying: Common Stock · 189 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options vested in four equal installments on the following dates: July 31, 2010, October 31, 2010, January 31, 2011 and April 30, 2011. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:11 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 112 | $87.50 | $9,800.00 |
DisclosureSEC source: 0001206264-20-000035 · wf-form4_157972747625593.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,765 F2 · kind: The sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| January 21, 2020 Filed Jan 22, 2020 21:11 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 189 | $33.33 | $6,299.37 |
DisclosureSEC source: 0001206264-20-000035 · wf-form4_157972747625593.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The conversion of stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| December 23, 2019 Filed Dec 23, 2019 21:03 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 189 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001206264-19-000217 · wf-form4_157713498407594.xml · derivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754 Underlying: Common Stock · 189 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options vested in four equal installments on the following dates: July 31, 2010, October 31, 2010, January 31, 2011 and April 30, 2011. Read SEC document |
| December 23, 2019 Filed Dec 23, 2019 21:03 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 76 | $89.41 | $6,795.16 |
DisclosureSEC source: 0001206264-19-000217 · wf-form4_157713498407594.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,688 F2 · kind: The sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| December 23, 2019 Filed Dec 23, 2019 21:03 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 189 | $33.33 | $6,299.37 |
DisclosureSEC source: 0001206264-19-000217 · wf-form4_157713498407594.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The conversion of stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 189 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001206264-19-000198 · wf-form4_157445653869040.xml · derivative · entry 6 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 943 Underlying: Common Stock · 189 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These stock options vested in four equal installments on the following dates: July 31, 2010, October 31, 2010, January 31, 2011 and April 30, 2011. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 975 | $0.00 Strike: $22.88 | $0.00 |
DisclosureSEC source: 0001206264-19-000198 · wf-form4_157445653869040.xml · derivative · entry 5 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 975 shares Expires 2019-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options vested on May 4, 2010, the date of the 2010 Annual Meeting of Stockholders. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 80 | $84.73 | $6,778.40 |
DisclosureSEC source: 0001206264-19-000198 · wf-form4_157445653869040.xml · nonDerivative · entry 4 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,575 F2 · kind: The sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 189 | $33.33 | $6,299.37 |
DisclosureSEC source: 0001206264-19-000198 · wf-form4_157445653869040.xml · nonDerivative · entry 3 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The conversion of stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | SaleCommon Stock | 281 | $84.73 | $23,809.13 |
DisclosureSEC source: 0001206264-19-000198 · wf-form4_157445653869040.xml · nonDerivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,466 F2 · kind: The sales of common stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:02 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionCommon Stock | 975 | $22.88 | $22,308.00 |
DisclosureSEC source: 0001206264-19-000198 · wf-form4_157445653869040.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The conversion of stock options reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019. Read SEC document |
| October 21, 2019 Filed Oct 23, 2019 20:05 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 189 | $0.00 Strike: $33.33 | $0.00 |
DisclosureSEC source: 0001206264-19-000176 · wf-form4_157186094660696.xml · derivative · entry 6 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132 Underlying: Common Stock · 189 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These stock options vested in four equal installments on the following dates: July 31, 2010, October 31, 2010, January 31, 2011 and April 30, 2011. Read SEC document |
| October 21, 2019 Filed Oct 23, 2019 20:05 UTC | SOMNIGROUP INTERNATIONAL INC. TPX · Entity 3403 | Exercise / conversionStock Options (right to buy) · Derivative | 977 | $0.00 Strike: $22.88 | $0.00 |
DisclosureSEC source: 0001206264-19-000176 · wf-form4_157186094660696.xml · derivative · entry 5 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975 Underlying: Common Stock · 977 shares Expires 2019-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These stock options vested on May 4, 2010, the date of the 2010 Annual Meeting of Stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.